Table 2 Univariate analysis of the correlation between clinicopathological parameters and survival of patients with gastric cancer
Clinicopathological parameters | Three-year cumulative survival rate | Log-Rank Test | p |
|---|---|---|---|
Gender | |||
 Male | 72.7 | 0.096 | 0.756 |
 Female | 80.0 |  |  |
Age (years) | |||
  > 60 | 75.6 | 0.102 | 0.749 |
  ≤ 60 | 70.5 |  |  |
Tumor size (cm) | |||
  > 5 | 69.9 | 1.435 | 0.231 |
  ≤ 5 | 76.8 |  |  |
Location of tumor | |||
 Lower 1/3 | 73.3 | 3.943 | 0.268 |
 Middle 1/3 | 82.6 |  |  |
 Upper 1/3 | 66.8 |  |  |
 More than 1/3 | 92.9 |  |  |
Degree of differentiation | |||
 Well/moderate | 78.7 | 0.332 | 0.564 |
 Poor and not | 70.8 |  |  |
Histological type | |||
 Papillary | 65.4 | 3.825 | 0.281 |
 Tubular | 83.6 |  |  |
 Mucinous | 66.7 |  |  |
 Signet-ring cell | 85.0 |  |  |
Depth of invasion | |||
 T1 + T2 | 100.0 | 5.357 | 0.021 |
 T3 + T4 | 70.1 |  |  |
Lymph node metastasis | |||
 Negative | 100.0 | 4.453 | 0.035 |
 Positive | 70.7 |  |  |
TNM stage | |||
 I + II | 97.4 | 12.542 | 0.000 |
 III + IV | 63.2 |  |  |
Distant metastasis | |||
 Negative | 75.9 | 6.798 | 0.009 |
 Positive | 40.0 |  |  |
UFM1 expression | |||
 Low | 69.1 | 4.946 | 0.026 |
 High | 93.1 |  |  |
PDK1 expression | |||
 Low | 82.3 | 5.990 | 0.014 |
 High | 64.3 |  |  |
UFM1/PDK1 expression | |||
 UFM1 high and PDK1 low | 100.0 | 11.290 | 0.010 |
 UFM1 and PDK1 high | 84.6 |  |  |
 UFM1 and PDK1 low | 78.0 |  |  |
 UFM1 low and PDK1 high | 58.4 |  |  |